Fibrin sealant topical has been assigned to pregnancy category C by the FDA. Animal reproduction studies have not been conducted with fibrin sealant topical. There are no controlled data in human pregnancy. Fibrin sealant topical should be given during pregnancy when need has been clearly established.

It is not known whether fibrin sealant topical can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity.

See references

There are no data on the excretion of fibrin sealant topical into human milk. Because many drugs are excreted in human milk, caution is recommended when fibrin sealant topical is administered to a lactating woman.

See references